This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty oncology medication. The contract has a total ceiling value of $8,016.30 and is a Firm Fixed Price Delivery Order, with a period of performance through December 6, 2024. The contract was awarded on November 14, 2024 and was not set aside for any specific business category. Amerisourcebergen, a for-profit organization, is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/13/25, 9:25 AM